Condition: Highly Sensitized Patients Awaiting Kidney Transplant · Sponsor: Tongji Hospital
The purpose of this study is to assess the safety, tolerability, and efficacy of AZD0120 in highly sensitized adult participants with ESKD awaiting kidney transplant-who, as assessed by investigators, are improbable desensitization through conventional treatments (e.g., plasmapheresis and immunoadsorption)- with or without living donors.
This description comes directly from the study's public registry record.
Gang Chen · 027-83662892 · gchen@tjh.tjmu.edu.cn
Always discuss trial participation with your own doctor first.
| Tongji Hospital, Tongji Medical Collage of Huazhong University of Science & Technology | Wuhan, Hubei, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07350837